News and Trends 4 Jan 2023
Aditxt forms Adimune to focus on immune modulation therapies
Aditxt, Inc., a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, has formed a U.S.-based subsidiary Adimune, Inc. The plan is…